Novigenix analyses large amounts of RNA data from different patients’ blood to generate precise information about the patient response to cancer, the evolution of the cancer, and response to treatment. Novigenix solutions employ cutting edge molecular technologies ranging from NGS to RT-PCR based platforms, and they leverage the company’s proprietary Immuno-Transcriptomics LITOSeek™ platform which has been optimized and standardized for integrating patient multi-omics data with advanced Machine Learning and artificial intelligence approaches to map the response of the immune system to onset and progression of disease. We are a pioneering company made up of experienced, bold and dedicated individuals with a clear understanding of complex host immune response pathways and data-driven intelligent algorithms. We provide new and actionable information on patient immune response to disease using expertise in immunology, molecular biology, bioinformatics, and machine learning to reveal, each day, more insights into the heterogeneity of host immune response for development of novel therapeutic modalities that can improve patient’s therapeutic journeys. We develop precise information about the risk and the stage of cancer, and likely response to immunotherapy. Over the past decade the Novigenix team has developed core competencies in development and measurement of RNA molecular biomarkers that are indicators of the presence or severity of a disease, in development of state-of-the-art data analytical models, and in regulatory approval of IVD products. We cooperate closely with biopharmaceutical companies and academic centers of excellence to leverage Immuno-Transcriptomics and improve our understanding of disease progression and response to therapy, integrating patient data and the host’s immune response to provide a holistic view of the tumor-host interaction. There is a gap in precise information to guide therapy development and clinical decision making.
This company is:
Verified
Novigenix_TechnologyByBilan - Novigenix
Novigenix_TechnologyByBilan | Share this content | About the Author: Margot Naëgelé | Recents posts
Verified
Philips3 - Novigenix
Philips3 | Share this content | About the Author: Sahar Hosseinian | Recents posts
View all products
Keywords
Industries
Where is NOVIGENIX located?
The company NOVIGENIX is located in Épalinges, Vaud, Switzerland. It's worth noting that the company may has more corporate locations
How many employees does NOVIGENIX approximately have?
As of the latest available information NOVIGENIX has around 11-50 employees worldwide.
When was NOVIGENIX founded?
NOVIGENIX was founded in 2014
In which industries does NOVIGENIX mainly work?
The company NOVIGENIX has it's main focus in the industries of Health Care, Artificial Intelligence, Data and Analytics, Science and Engineering, Biotechnology, Professional Services
NovalGen
United Kingdom
11-50 Employees
2019
Novogenia
Austria
11-50 Employees
2009
Caligenix
United States
11-50 Employees
2017
NeoGenomics
United States
501-1000 Employees
2002
genix.ai
India
1-10 Employees
2021
Inivata
United States
51-100 Employees
2014
Nexomics
Australia
11-50 Employees
2014
Lifecode
United States
1-10 Employees
2011
Topics which have been searched by others and may be interesting for you: